Pediatr. praxi. 2013;14(1):39-41

Diagnosis and treatment of children with ADHD and comorbid anxiety

prof.MUDr.Ivana Drtílková, CSc.
Psychiatrická klinika FN Brno a LF Masarykovy univerzity v Brně

ADHD is often comorbid with anxiety disorders, with rates approaching 25–35 % in many samples of patiens. Recent studies indicate that

anxiety in ADHD may partially inhibit the impulsivity and make working memory deficits worse. The subgroups may have differing clinical

courses, and pharmacological responses. Studies examining stimulant response in children with ADHD/anxiety have recently yielded

conflicting results. Atomoxetine was efficacious in reducing ADHD symptoms in patients who have ADHD with comorbid anxiety and

was well tolerated.

Keywords: ADHD, comorbid anxiety, stimulants, atomoxetine

Published: February 15, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Drtílková I. Diagnosis and treatment of children with ADHD and comorbid anxiety. Pediatr. praxi. 2013;14(1):39-41.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Shaw P, Gilliam M, Liverpool M, et al. Typically Developing Children With Symptoms of Hyperactivity and Impulsivity: Support for a Dimens Cortical Development in ional View of Attention Deficit Hyperactivity Disorder. Am J Psychiatry 2011; 168: 143-151. Go to original source... Go to PubMed...
    2. Drtílková I, Šerý O, Theiner P, et al. Clinical and molecular - genetic markers of ADHD in children. Neuroendocrinology Letters 2008; 29(3): 320-327. Go to PubMed...
    3. Stein MB, Schork NJ, Gelernter J. Gene-by-environment (serotonin transporter and childhood maltreatment) interaction for anxiety sensitivity, an intermediate phenotype for anxiety disorders. Neuropsychopharmacology 2008; 33: 312-319. Go to original source... Go to PubMed...
    4. Malá E. Úzkostné poruchy v dětství. Čes a Slov Psychiatr 2011; 107(2): 99-105.
    5. S?rensen L, Kerstin J, Plessen J. Is Behavioral Regulation in Children With ADHD Aggravated by Comorbid Anxiety Disorder? Journal of Attention Disorders 2011; 15(1): 56-66. Go to original source... Go to PubMed...
    6. Beck D, Schatz A, Rostain L. ADHD With Comorbid Anxiety A Review of the Current Literature Journal of Attention Disorders 2006; 10(2): 141-149. Go to original source... Go to PubMed...
    7. Mikami A, Ransone M. Influence of Anxiety on the Social Functioning of Children With and Without ADHD. Journal of Attention Disorders 2011; 15(6): 473-484. Go to original source... Go to PubMed...
    8. Bowen R, Chavira DA, Bailey K, et al. Nature of anxiety comorbid with attention deficit hyperactivity disorder in children from a pediatric primary care setting. Psychiatry Res 2008; 15(1-3): 201-209. Go to original source... Go to PubMed...
    9. Mayes S, Calhoun S, Bixler P. ADHD Subtypes and Comorbid Anxiety, Depression, and Oppositional-Defiant Disorder: Differences in Sleep Problems. Oxford Journals Medicine Journal of Pediatric Psychology 2008; 34 (3): 328-337. Go to original source... Go to PubMed...
    10. Drtílková I, Hrdlička M, Paclt I. Farmakoterapie hyperkinetické poruchy In: Raboch J, et al. Psychiatrie. Doporučené postupy psychiatrické péče II, 2007: 1-9.
    11. Garcia SP, Guimar?es J, Zampieri JF, et al. Response to methylphenidate in children and adolescents with ADHD: does comorbid anxiety disorders matters? J Neural Transm. 2009; 116(5): 631-636. Go to original source... Go to PubMed...
    12. Goes H. Differential Stimulant Response on Attention in Children With Comorbid Anxiety and Oppositional Defiant Disorder. J Child Neurol 2007; 22: 538-542. Go to original source... Go to PubMed...
    13. Blouin B, Maddeaux C, Firestone SJ, et al. Predicting response of ADHD symptoms to methylphenidate treatment based on comorbid anxiety. J Atten Disord. 2010; 13(4): 414-419. Go to original source... Go to PubMed...
    14. Coffey B, Kelsey D, Feldman P, et al. Atomoxetine treatment in children with ADHD and comorbid tic disorders. Presented at: American Psychiatric Association Annual Scientific meeting: New York, May 1-6, 2004.
    15. Graham J, Banaschewski T. European guidelines on managing adverse effects of medication for ADHD. Eur Child Adolesc Psychiatry 2011; 20: 17-37. Go to original source... Go to PubMed...
    16. Allen AJ. Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders. Neurology 2005; 65(12): 1941-1949. Go to original source... Go to PubMed...
    17. Sangal RB, Owens J, Allen AJ, et al. Effects of atomoxetine and methylphenidate on sleep in children with ADHD. Slep 2006; 29(12): 1573-1585. Go to original source... Go to PubMed...
    18. Geller D, Donnelly C, Lopez F, Rubin R. Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder. J Am Acad Child Adolesc Psychiatry 2007; 46(9): 1119-1127. Go to original source... Go to PubMed...
    19. Adler LA, Liebowitz M, Kronenberger W, et al. Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder. Depress Anxiety 2009; 26(3): 212-221. Go to original source... Go to PubMed...

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.